Atrial fibrillation: It is better to be alone than in bad company!

Chest

Volumn 141, Issue 2, 2012, Pages 290-292

  Boriani, Giuseppe ^a   Diemberger, Igor ^a   Biffi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL RESEARCH; COMORBIDITY; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; PATIENT MONITORING; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STROKE; THROMBOEMBOLISM;

EID: 84856711989     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1339     Document Type: Editorial

References (11)

1. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271(11):840-844.
2. Boriani G, Diemberger I, Martignani C, Biffi M, Branzi A. The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems. Eur Heart J. 2006;27(8):893-894.
3. Evans W, Swann P. Lone auricular fibrillation. Br Heart J. 1954;16(2):189-194.
4. Fuster V, Rydén LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011;57(11):e101-e198.
5. Potpara TS, Stankovic GR, Beleslin BD, et al. A 12-year follow-up study of patients with newly-diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: The Belgrade Atrial Fibrillation Study. Chest. 2012; 141(2):339-347.
6. Camm AJ, Kirchhof P, Lip GY, et al; European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology. Europace. 2010;12(10): 1360-1420.
7. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL; Stroke Prevention in Atrial Fibrillation Investigators. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. J Am Coll Cardiol. 2000;35(1):183-187. (Pubitemid 30061278)
8. Boriani G, Botto GL, Padeletti L, et al; for the Italian AT-500 Registry Investigators. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke. 2011;42(6):1768-1770.
9. Gage BF, van Walraven C, Pearce L, et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation. 2004;110(16): 2287-2292. (Pubitemid 39407328)
10. de Vos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010;55(8):725-731.
11. Potpara TS, Lip GYH. Lone atrial fibrillation: what is known and what is to come. Int J Clin Pract. 2011;65(4):446-457.